Table 3.
Treatment group | Median preoperative concentration* (interquartile range) | Median 6-month concentration (interquartile range) | Median year 1 concentration (interquartile range) | Median year 2 concentration (interquartile range) | Intragroup p value|| | Intergroup p value¶ (MOP and MOM) | Intergroup p value (MOM28 and MOM 36) |
---|---|---|---|---|---|---|---|
Erythrocyte chromium | |||||||
MOP† | 1.00 (0.75–1.45) | 1.20 (0.80–1.58) | 1.20 (0.70–1.60) | 1.10 (0.70–1.73) | 0.609 | ||
MOM28‡ | 1.20 (1.10–1.55) | 1.20 (0.80–1.60) | 1.10 (0.87–1.42) | 1.10 (0.60–1.70) | 0.198 | 0.864 | |
MOM36§ | 0.90 (0.70–1.47) | 1.10 (0.80–1.68) | 1.20 (1.00–1.85) | 1.20 (0.78–1.63) | 0.525 | 0.527 | 0.427 |
Serum chromium | |||||||
MOP | 0.20 (0.13–0.29) | 0.20 (0.14–0.32) | 0.24 (0.13–0.37) | 0.17 (0.12–0.29) | 0.904 | ||
MOM28 | 0.22 (0.10–0.28) | 0.99 (0.49–1.30) | 1.07 (0.65–1.46) | 1.29 (0.77–1.72) | < 0.001 | < 0.001 | |
MOM36 | 0.21 (0.12–0.34) | 0.97 (0.55–1.39) | 1.06 (0.61–1.63) | 0.91 (0.64–1.78) | 0.001 | < 0.001 | 0.600 |
Urine chromium | |||||||
MOP | 0.30 (0.15–0.49) | 0.30 (0.18–0.50) | 0.31 (0.22–0.37) | 0.27 (0.19–0.53) | 0.819 | ||
MOM28 | 0.24 (0.18–0.46) | 1.64 (0.74–2.19) | 1.88 (1.20–2.40) | 1.92 (1.44–2.90) | < 0.001 | < 0.001 | |
MOM36 | 0.36 (0.18–0.58) | 1.65 (1.19–2.17) | 1.80 (1.33–3.04) | 2.02 (1.08–3.74) | < 0.001 | < 0.001 | 0.788 |
*All concentrations are given in μg/L; †MOP = patients randomized to metal-on-polyethylene THA; ‡MOM28 = patients randomized to metal-on-metal, 28-mm THA; §MOM36 = patients randomized to metal-on-metal, 36-mm THA; ||intragroup p value = difference in preoperative and 2-year postoperative chromium ion concentrations within each group using the Wilcoxon test; ¶intergroup p value = difference in chromium ion concentrations at the 2-year postoperative interval between the metal-on-polyethylene group and each of the metal-on-metal groups and between the two metal-on-metal groups, using the Mann-Whitney test.